World Hemophilia Day

April 17, 2018

April 17, 2018 marks the 28th World Hemophilia Day! Boston Biopharma is committed to share knowledge and increase awareness about hemophilia, our goal is to improve access to care and treatment. Boston Biopharma CSR team is working toward bringing awareness to the medical community and families during World Hemophilia Day 2018.


2018 Microsoft Health Innovation Awards

March 8, 2018

Congratulations to all the Winners of the 2018 Microsoft Health Innovation Awards! BB team is honored that Dr. Ahmad Hashem the CEO of Boston Biopharma is a distinguished judge who reviewed this year’s innovative solutions award. Discover how they're advancing digital transformation in health.

Clinical Skills Training

March 8, 2018

In the first phase of a capacity building project to improve the clinical skills of Kurdish health care providers who work with children who have hemophilia, Dr. April Gamble, a doctor of physical therapy, spent two months training the nurses at Nanakali Hospital how to work with this population. The training includes how to address acute bleeds and guidelines for returning to activity, including exercise prescription. 

During the next phase, these nurse trainers will use their new found skills to educate and empower children with hemophilia and their families."

CPhI Worldwide, Frankfort 2017

November 6, 2017

Boston Biopharma participated in the world’s leading pharmaceutical platform, CPhI Worldwide this past October. CPHI Worldwide hosts more than 45,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. Every sector of the pharmaceutical market was represented under one roof, this year in Frankfurt. During CPhI Worldwide this year, Boston Biopharma proudly launched MAXINIB (TM), the first generic of Sunitinib in the market, listed as a first-line therapy options for patients with relapsed or stage IV and surgically unresectable with predominantly clear cell renal cell carcinoma.

BEAR Saves Lives. Bhutan Project Receives Medical Humanitarian Award

October 1, 2017

BEAR Saves Lives
Bhutan Project Receives Medical Humanitarian Award from Boston Biopharma

(Alpharetta, GA, USA)- October 1, 2017- The Bhutan Emergency Aeromedical Retrieval (BEAR) team will be awarded the Medical Humanitarian Award. Established and presented by Boston Biopharma, a USA-based pharmaceutical company that specializes in generic medications, the award aims to identify and recognize exceptional new healthcare programs that impact the lives of patients in underserved areas around the globe. The award will be presented to Dr. Charles Haviland Mize, MD, and the Bhutan Emergency Aeromedical Retrieval team (BEAR) for their volunteer efforts in helping save lives in Bhutan, on October 2nd 2017. In addition to the award, and in response to the Bhutan Foundation’s campaign for funding, BEAR will be receiving a donation from Boston Biopharma to help further expand the program with much needed medical equipment.

Dr. Mize worked with the Royal Government of Bhutan’s Ministry of Health, Royal Bhutan Helicopter Services and Jigme Dorji Wangchuck National Referral Hospital (JDWNRH) to develop the Bhutan Aeromedical Retrieval Team (BEAR.) The aim of BEAR is to provide cutting-edge resuscitation and critical obstetric care to patients in remote parts of Bhutan including the Himalayas. The team is trained to respond to emergency evacuations in extreme altitudes using a high-performance helicopter equipped with an intensive care unit to transport patients safely to hospitals.

The idea of BEAR was born in 2016 when the life of a patient with a treatable injury could not be saved because he arrived too late to the hospital. Many such incidences have been occurring throughout the country. Since its inception in May 2017, the program has been an incredible success saving 53 patients across the country. The BEAR team responds to all life-threatening emergencies and provides elite trauma and medical resuscitation to patients in district hospitals or on site as required.
The BEAR team was initially led by Dr. Mize and emergency nurses Lhab Dorji and Kiran Diyali . Three more doctors and two emergency nurses have joined the team led by Dr. Ugyen Tshering and Dr. Sona Pradhan at the JDWNRH emergency department. BEAR could not be possible without the support and collaboration of the Bhutan Foundation, the Emergency Medical Services Division under the Health Ministry and the Jigme Dorji Wangchuck National Referral Hospital (JDWNRH).

Additionally, Dr. Mize will be returning to Bhutan in October 2017 to further develop a high-altitude mountain rescue program for Bhutan. He will continue in his positions as Head of Bhutan Emergency Aeromedical Retrieval and Head of Resuscitation at JDWNRH. The BEAR team will also be ensuring the sustainability of the life-saving program by helping train Bhutanese physicians and nurses.

“Dr. Mize’s efforts represent the selfless dedication to serve patients and save lives,” said Ahmad Hashem, MD, Ph.D., Chief Executive Officer at Boston Biopharma. “We are honored to support his work and the Bhutan Foundation to provide needed medical equipment. We are also exploring options to work with the Bhutan Cancer Society to provide anti-cancer medications to the country.”
Dr. Mize is an emergency medicine physician who completed his Emergency Medicine Residency at George Washington University in Washington D.C., his medical degree at Columbia University College of Physicians and Surgeons, and his undergraduate degree from Yale University. For the past year, he has volunteered at the Jigme Dorji National Referral Hospital in Thimphu, Bhutan in collaboration with the Bhutan Foundation and Health Volunteers Overseas to help improve emergency medical services in Bhutan.
Boston Biopharma is a US company focused on the development of generic pharmaceuticals, and is dedicated to furthering excellence in healthcare. The company began administering this award with the goal of raising the awareness of healthcare organizations and individuals who go beyond the ordinary in providing care to populations in underserved areas. To date, the company has launched 12 sophisticated oncology products and has operations in America, Europe (Malta), Turkey, Iraq, Algeria, and Ukraine.

Visit us at CPHI

September 17, 2017

Boston Biopharma is proud to be part of CPHI Worldwide, October 24-26, Messe Frankfort, Germany.

Second ASCO Conference

September 23, 2017

Boston BioPharma is proud to be part of Second ASCO Conference, September 28-29, Erbil.

Second ASCO Conference

September 26, 2017

Boston Biopharma is proud to be part of Second ASCO Conference, September 28-29, Erbil.
Session 1: 29/09/2017
Gastrointestinal Cancer (colorectal) 14:00-15:00
Session 2: 29/9/2017
Gastrointestinal Cancer (non-colorectal)
15:10- 16:10